// App-Quantinova.ai

LB 02.1 : Intermediate versus low-dose low-molecular-weight heparin in pregnant and postpartum women with a history of venous thromboembolism (Highlow Study)

Researchers

Presenter

  • I. Bistervels

Principal Investigators

  • H. Wiegers

  • F. N inle

  • B. Tardy

  • J. Donnelly

  • P. Verhamme

  • A. Hansen

  • M. Rodger

  • M. DeSancho

  • N. van Es

  • M. Prins

  • C. Chauleur

  • S. Middeldorp

Medical Centers

  • 1) Amsterdam UMC location University of Amsterdam, Department of Vascular Medicine, Amsterdam, the Netherlands 2) Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, the Netherlands, Amsterdam, Noord-Holland, Netherlands

  • Service de Médecine Vasculaire et Thérapeutique, CHU Saint Etienne, Saint-Étienne, Rhone-Alpes, France

  • 1. Amsterdam University Medical Centers, University of Amsterdam; 2. Tergooi Medical Center, Amsterdam, Noord-Holland, Netherlands

  • Department for Haematology, Mater Misericordiae University Hospital, Ireland, Dublin, Dublin, Ireland

  • INSERM, CIC-1408, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne, France, St Etienne, Rhone-Alpes, France

  • ) Department of Obstetrics and Gynaecology, Rotunda Hospital and Mater Misericordiae University Hospital, Dublin, Ireland 2) Royal College of Surgeons in Ireland, Dublin, Ireland 3) School of Medicine, University College Dublin (UCD), Dublin, Ireland, Dublin, Dublin, Ireland

  • Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KULeuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium

  • ) Department of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway 2) Faculty of Medicine, University of Oslo, Hospital, Oslo, Norway, Oslo, Oslo, Norway

  • ) Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark 2) Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Midtjylland, Denmark

  • Department of Medicine, McGill University Health Center, Montréal, Quebec, Canada., Montreal, QC, Canada

  • Montefiore Medical Center, Medicine, New York, United States

  • Institute of Obstetrics, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, Ministry of Healthcare of the Russian Federation, Moscow, Russia, Moscow, Moskva, Russia

  • Department of Epidemiology and Technology Assessment, University of Maastricht, Maastricht, the Netherlands, Maastricht, Limburg, Netherlands

  • 1) Service de Gynécologie Obstétrique, Centre Hospitalier Universitaire de St-Etienne, Saint-Etienne, France 2) INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, F-42055, Saint-Etienne, France, St-Etienne, Rhone-Alpes, France

  • Radboud University Medical Center, Njmegen, Netherlands

Locations

  • Netherlands

  • France

  • Ireland

  • Belgium

  • Norway

  • Denmark

  • Canada

  • United States

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multinational

Phase

  • NA

Study Id's

  • NCT01828697

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved